NASDAQ: SLSNSolesence Inc Stock
$2.28+0.03 (+1.33%)
Updated Apr 22, 2025
SLSN Price
$2.28
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$1.36
52 Week High
$16.56
P/E
32.57x
P/B
N/A
P/S
N/A
PEG
1.89x
Dividend Yield
N/A
Revenue
$52.35M
Earnings
$4.24M
Gross Margin
30.9%
Operating Margin
9.8%
Profit Margin
8.1%
Debt to Equity
2.35
Operating Cash Flow
$2M
Beta
0.19
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SLSN Overview
Solésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The company partners with global and indie brands, leveraging its proprietary Active Stress Defense™ technology suite to bring environmental protection beauty products to market.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SLSN's potential to beat the market
- SLSN doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Household & Personal Product
Industry Rating
C
SLSN
RankedUnranked of 25
RankedUnranked of 25
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $25.35 | B | |
| $4.08 | C | |
| $65.43 | C |
Be the first to know about important SLSN news, forecast changes, insider trades & much more!
SLSN News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SLSN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SLSN ($2.28) is trading above its intrinsic value of $0.79, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SLSN is poor value based on its earnings relative to its share price (32.57x), compared to the US market average (28.14x)
P/E vs Market Valuation
SLSN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more SLSN due diligence checks available for Premium users.
Valuation
SLSN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
32.57x
Industry
26.2x
Market
28.14x
SLSN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SLSN is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
SLSN price to earnings growth (PEG)
For valuing profitable companies with growth potential
SLSN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
SLSN's financial health
Profit margin
Revenue
$12.6M
Net Income
-$558.0k
Profit Margin
-4.4%
SLSN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SLSN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$50.0M
Liabilities
$35.1M
Debt to equity
2.35
SLSN's short-term assets ($29.35M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SLSN's short-term assets ($29.35M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SLSN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SLSN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$2.2M
Investing
-$2.6M
Financing
-$1.1M
SLSN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SLSN vs Household & Personal Product Stocks
Solesence Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.